Related Experiment Video
Updated: Aug 6, 2026
06:59
Characterization of Metabolic Status in Nonhuman Primates with the Intravenous Glucose Tolerance Test
Published on: November 13, 2016
Summary and perspectives on impaired glucose tolerance
1Mt Sinai Medical Center, Cleveland, Ohio 44106, USA.
Summary
Impaired glucose tolerance (IGT) is linked to diabetes and heart disease, but its exact role as a cause or marker needs more research. Understanding this relationship is key for developing effective preventive therapies for individuals with IGT.
Area of Science:
- Endocrinology
- Metabolic Disorders
- Cardiovascular Health
Background:
- Impaired glucose tolerance (IGT) is associated with increased risks of non-insulin dependent diabetes mellitus (NIDDM) and cardiovascular disease.
- The precise role of IGT—whether a marker, risk factor, or causal agent—in the pathogenesis of these conditions remains unclear.
- The probability of developing NIDDM or cardiovascular disease among individuals with IGT may vary, necessitating further investigation.
Purpose of the Study:
- To elucidate the pathogenetic relationship between impaired glucose tolerance and the development of non-insulin dependent diabetes mellitus and cardiovascular disease.
- To clarify whether impaired glucose tolerance is a causal factor or merely a marker for these serious health conditions.
- To inform the potential development of preventive therapies for individuals diagnosed with impaired glucose tolerance.
Main Methods:
- Observational studies analyzing the progression of individuals with impaired glucose tolerance.
- Epidemiological research correlating impaired glucose tolerance with incidence of non-insulin dependent diabetes mellitus and cardiovascular events.
- Longitudinal studies tracking metabolic changes and disease outcomes in at-risk populations.
Main Results:
- Evidence suggests a strong link between impaired glucose tolerance and increased risk for non-insulin dependent diabetes mellitus and cardiovascular disease.
- Current data are insufficient to definitively establish impaired glucose tolerance as a causal factor or to justify routine therapeutic interventions.
- Further research is required to understand the variability in outcomes among individuals with impaired glucose tolerance.
Conclusions:
- Impaired glucose tolerance is a significant risk factor, but its causal role in non-insulin dependent diabetes mellitus and cardiovascular disease requires further investigation.
- The potential for widespread preventive therapy hinges on a clearer understanding of the pathogenetic mechanisms linking impaired glucose tolerance to these diseases.
- More research is crucial to determine if impaired glucose tolerance represents a distinct stage in disease development warranting intervention.
More Related Videos
08:32Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Related Concept Videos
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Diabetes: Symptoms, Diagnosis, and Complications
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is based on...
01:26Diabetes Mellitus: Introduction
Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...